Modified molecules which promote hematopoiesis

Details for Australian Patent Application No. 2007222526 (hide)

Owner AplaGen GmbH

Inventors Frank, Hans-Georg; Haberl, Udo

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007222526

PCT Pub. Number WO2007/101698

Priority 06010174.8 17.05.06 EP; 06004833.7 09.03.06 EP; 60/780,568 09.03.06 US; 60/747,515 17.05.06 US

Filing date 9 March 2007

Wipo publication date 13 September 2007

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

30 October 2008 PCT application entered the National Phase

  PCT publication WO2007/101698 Priority application(s): WO2007/101698

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222528-Method for providing certain information

2007222491-Tidal energy system